Review of Ethical and Scientific Aspects of Acupuncture Clinical Trials Pointed Out by Institutional Review Board a Part of Development Process of the Acupuncture and Moxibustion Clinical Research Guideline

Article information

Acupunct. 2015;32(2):11-21
1Korean Medicine Clinical Trial Center, Kyung Hee University
2Department of Clinical Research of Korean Medicine, Kyung Hee University
3Department of Acupuncture and Moxibustion Medicine, Kyung Hee University
4Department of Gastroenterology, Kyung Hee University
5Department of Acupuncture and Moxibustion Medicine, Dongguk University
6Department of Acupuncture and Moxibustion Medicine, Woosuk University
7Department of Sasang Constitutional Medicine, Kyung Hee University
*Corresponding author: Dong Woo Nam: Korean Medicine Clinical Trial Center, College of Korean Medicine, Kyung Hee University, 23, Kyungheedae-ro, Dongdaemun-gu, Seoul, 130-872, Republic of Korea, Tel: +82-2-958-9202, E-mail: hanisanam@hanamil.net; Jun Hee Lee: Korean Medicine Clinical Trial Center, College of Korean Medicine, Kyung Hee University, 23, Kyungheedae-ro, Dongdaemun-gu, Seoul, 130-872, Republic of Korea, Tel: +82-2-958-9280, E-mail: ssljh@hanmail.net
Received 2015 April 06; Revised 2015 April 16; Accepted 2015 April 22.

Abstract

Objectives:

To improve quality of clinical research for acupuncture and moxibustion, a guideline for clinical research protocol is needed. While developing a guideline for acupuncture and moxibustion clinical research, we reviewed the ethical and scientific aspects of protocols pointed out by the institutional review board. This will offer practical assistance to the researchers.

Methods:

Ethical and scientific aspects of acupuncture and moxibustion research protocols reviewed by Kyung Hee University Korean Medicine Hospital Institutional Review Board were gathered and reviewed.

Results:

Ethical and scientific aspects of protocol review was reported.

Conclusions:

The example of review will be helpful for new researchers when developing acupuncture and moxibustion clinical research protocol.

Notes

This study was supported by the Traditional Korean Medicine R&D program funded by the Ministry of Health and Welfare through the Korean Health Industry Development Institute(KHIDI)(No. HI13C0700)

Appendices

Appendix 1.

Ethical and Administrative Review Pointed Out by IRB

Appendix 2.

Screview Review Pointed Out by IRB

References

1. Gu J, Zhao Y, Wang X, Jiang J, Tian J, Yang K. Registration quality assessment of acupuncture clinical trials. PLoS ONE 2013;8(3):e59506. 10.1371/journal.pone.0059506.
2. Birch S. Clinical research on acupuncture: Part 2. Controlled clinical trials, an overview of their methods. J Altern Complement Med 2004;10(3):481–98.
3. Shuai P, Zhou X-H, Lao L, Li X. Issues of design and statistical analysis in controlled clinical acupuncture trials: an analysis of English-language reports from western journals. Stat Med 2012;31(7):606–18.
4. Kim JE, Kang KW, Kim TH, et al. A systematic review and meta-analysis of acupuncture trials in republic of Korea that used sham acupuncture as a control group the acupuncture. The Acupuncture 2011;28(6):1–17.
5. Jang JY, Kim SJ, Kim NS, Nam SS, Kim YS. Review and analysis of sham acupuncture in acupuncture clinical trials. The Acupuncture 2011;28(5):29–38.
6. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332. 10.1136/bmj.c332.
7. MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture(STRICTA): extending the CONSORT statement. PLoS Med 2010;7(6):e1000261. 10.1371/journal.pmed.1000261.
8. Gagnier JJ, Boon H, Rochon P, et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006;144(5):364–7.
9. Lee HS, Cha SJ, Park HJ, Seo JC, Park JB, Lee HJ. Revised STandards for Reporting Intervetions in Clinical Trials of Acupuncture(STRICTA): extension the CONSORT statement. Korean Journal of Acupuncture 2010;27(3):1–23.
10. Kim WY, Lee SD, Lim BM, Kim KS. The assessment of appropriatesness of acupuncture methodology based on STRICTA recommendations. The Acupuncture 2007;24(5):151–70.
11. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE initiative. Strengthening the reporting of observational studies in epidemiology(STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335(7624):806–8.
12. Des Jarlais DC, Lyles C, Crepaz N. TREND group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004;94(3):361–6.
13. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta analyses. Lancet 1999;354(9193):1896–900.
14. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996;17(1):1–12.
15. Kim YY, Yoo JH, Lee SK, Lee SW. Quality assessment of randomized controlled trials using herbal remedies in Korea. Korean J Oriental Physiology & Pathology 2007;25(5):927–33.
16. World Health Organization Regional Office for the Western Pacific. Guideline for clinical research on acupuncture WHO Regional Publications. Western Pacific Series No. 15. 1995.
17. Kim KS, Yoon JH, Kim KH, Jang JH, Lee SD. Guideline for clinical reasearch on acupuncture. The Acupuncture 2003;20(5):1–27.
18. MacPherson H, Hammerschlag R, Lewith GT, Schnyer RN. Acupuncture Research Seoul: Elsevier Korea; 2009.
19. Lee SD. An assessment of statistical validity of articles published in the Journal of Korean Acupuncture & Moxibusition Society: from 1984 to 2002. The Acupuncture 2004;21(1):176–88.
20. Kwon YK. Development of Korean medicine clinical study guideline. Health Industry Technology Trend 2006;Summer. :128–34.
21. Zaslawski C. Ethical considerations for acupuncture and chinese herbal medicine clinical trials: a cross-cultural perspective. Evid-Based Complement Altern Med 2010;7(3):295–301.
22. Hammerschlag R. Methodological and ethical issues in clinical trials of acupuncture. J Altern Complement Med 1998;4(2):159–71.
23. White AR, Filshie J, Cummings TM. International acupuncture research forum. Clinical trials of acupuncture: consensus recommendations for optimal treatment, sham controls and blinding. Complement Ther Med 2001;9(4):237–45.
24. Sherman KJ, Cherkin DC. Challenges of acupuncture research: study design considerations. Clin Acupunct Orient Med 2002;3(4):200–6.
25. Gu J, Wang Q, Wang X, et al. Assessment of registration information on methodological design of acupuncture RCTs: a review of 453 registration records retrieved from WHO international clinical trials registry platform. Evid Based Complement Alternat Med 2014;:1–8. 10.1155/2014/614850.
26. Korea Food and Drug Administration Herbal Medicine Policy Division. Evaluation guideline of herbal medicine clinical trial: antitussive expectorant medicine. Korea Food and Drug Administration. Seoul 2007;:6.
27. Jung HJ, Park JE, Choi SM. Current status of institutional review boards and approvals of clinical research in oriental medical hospitals in Korea: a survey. J Korean Oriental Med 2010;31(1):122–9.
28. Korea Food and Drug Administration Biopharmaceutical Policy Division. Guideline for biopharmaceutical clinical trial protocol writing: frequently, commonly indicated statistic improvoment point. Korea Food and Drug Administration Biopharmaceutical Policy Division. Seoul 2013;:12.
29. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache. Cochrane Database Syst Rev 2009;(1):CD007587. 10.1002/14651858.CD007587.
30. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009;(1):CD001218. 10.1002/14651858.CD001218.pub2.
31. Hopwood V, Lewith G. Acupuncture trials and methodological considerations. Clin Acupunct Orient Med 2003;3(4):192–9.
32. Elizabeth AB, Robert JA. Institutional review board: management and function 1st editionth ed. Seoul: GCO Science; 2011. p. 353–61.
33. Linde K, Dincer F. How informed is consent in sham-controlled trials of acupuncture? J Altern Complement Med 2004;10(2):379–85. 10.1089/107555304323062374.

Article information Continued

Ethical and Administrative Review Pointed Out by IRB

Screview Review Pointed Out by IRB